NJ MPJE common mistakes
NJ MPJE · Understand the traps and how to avoid them.
Accepts a Schedule II prescription that is missing a required element (quantity, dosage form, patient address, prescriber DEA number) and says 'I'll get the missing piece from the office after I fill it.'
Candidates memorize the list of required elements but never rehearse what to do when one is absent; under time pressure they default to the retail habit of 'call and clarify later,' which is legitimate for some Schedule III-V corrections but not for a face-valid CII.
What to do instead
Before answering any 'can I fill this?' item, recite the element checklist (patient name/address, drug, strength, dosage form, quantity, directions, date, prescriber name/address/DEA, manual signature or valid EPCS) and then classify the defect: a missing CII element generally requires a corrected/new prescription before dispensing, while limited items (e.g., dosage form, direction clarification after consultation) may be corrected under defined conditions. State in your answer: 'I would not dispense until X is corrected, and I would document the call.'
Treats the federal Controlled Substances Act as the ceiling for every controlled-substance question and never asks whether New Jersey imposes a tighter rule (or vice versa), so answers describe the federal refill/validity rule on an item that is actually testing a stricter state limit.
Most study time goes to the federal framework because it is uniform and easier to memorize; state overlays feel like exceptions, so candidates answer with the rule they know best rather than the rule that controls.
What to do instead
Adopt a fixed two-pass method for every controlled-substance item: (1) what does the federal CSA permit, (2) does New Jersey restrict it further? Write both in your scratch notes and answer with the stricter requirement. When a rule is genuinely unclear, say what document you would consult (NJ Board regulations, NJ CDS Act, DEA rule) instead of guessing a number.
Handles DEA Form 222/CSOS ordering and inventory carelessly in scenarios: accepts a photocopied or altered 222, fails to date and record the quantity received on the receiving copy, lets an unauthorized employee sign, or schedules the biennial inventory without covering all required stock.
Ordering and inventory are treated as 'back-office paperwork' that candidates skim, so they cannot describe the paper trail precisely when a scenario asks who may sign or what must be annotated on receipt.
What to do instead
Memorize the 222 workflow as a sequence: who may execute (registrant or a person holding a valid power of attorney on file), what copy goes where, what must be annotated at receipt (date received and quantity), and what must be retained and for how long. Pair it with the inventory rule (biennial, all controlled substances on hand, exact count for Schedule II) and practice stating the sequence aloud in order.
Assumes a pharmacist or technician licensed/registered in another state may work in a New Jersey pharmacy without NJ credentials, or lets an unregistered technician perform duties reserved to a registered technician or to a pharmacist.
Candidates conflate 'nationally recognized certification' (e.g., PTCB) with state registration, and they underestimate how heavily the Board tests personnel categories, registration status, and task delegation.
What to do instead
Build a one-page grid of New Jersey personnel categories (pharmacist, pharmacy intern, registered pharmacy technician, technician candidate, clerk) with columns for credential required, who may supervise, and which tasks are prohibited. For any scenario, first ask 'what is this person's NJ credential and status?' before evaluating the task itself.
Fills a controlled substance prescription written on an out-of-state or non-official blank, or one that arrived by a route the state does not permit, without checking New Jersey's prescription-form and electronic-prescribing requirements and exceptions.
Candidates learn 'CDS prescriptions need a special form' as a slogan, then fail to test the form's origin, serialization, and whether an exception (e.g., electronic prescribing with a valid waiver, emergency situation) actually applies to the facts given.
What to do instead
For every CDS prescription item, explicitly check three things out loud: the form type and issuing state, the transmission method, and whether a recognized exception applies. If the facts do not establish a valid NJ-compliant form or exception, state that you cannot dispense and identify what you would verify (prescriber NJ registration status, official form, waiver) before filling.
Skips or truncates the offer to counsel because the patient is a regular, is picking up a refill, is at a drive-through/mail-order channel, or signed a blanket waiver at intake that is never revisited.
Candidates picture counseling as a scripted conversation in a quiet pharmacy and do not recognize that the obligation attaches to each dispensing and must be documented when declined; refills and alternate channels feel exempt.
What to do instead
Treat counseling as an event with three parts you must be able to name in your answer: the offer, who may make it (pharmacist or appropriately supervised intern, not a clerk), and the documentation when it is declined. On every scenario, ask 'was the offer made at this dispensing, by a qualified person, and is the refusal documented for this fill?'
Uses 'substitution' and 'therapeutic interchange' interchangeably, so the answer substitutes a different drug or different strength under a generic-substitution rule, or applies an institutional interchange protocol at a community pharmacy without prescriber authorization.
The two concepts share vocabulary, and exam items deliberately place them in similar fact patterns; candidates answer the concept they studied last rather than the one the facts describe.
What to do instead
Anchor the distinction before reading the options: generic substitution = same drug, same strength/dosage form, different manufacturer, permitted under state substitution law with the required patient/prescriber handling; therapeutic interchange = different drug or regimen, requires prescriber authorization or a valid protocol. Then check the NJ-specific guardrails (state negative formulary/prohibited substitutions, patient notification, documenting and passing on savings).
Assigns a beyond-use date to a compounded preparation from habit or from the label on the bulk container, and applies sterile-preparation expectations to a non-sterile compound (or overlooks water source, environmental monitoring, and designated oversight for sterile work).
Compounding is often studied as a list of numbers without the decision tree that selects them, so candidates cannot tell which standard and which BUD category govern the scenario.
What to do instead
Practice a three-step decision tree for every compounding item: (1) sterile or non-sterile, (2) which USP chapter and which BUD category applies (and whether a shorter default is required), (3) who is responsible for oversight, training, and facility/engineering documentation. Only after classifying do you state a BUD, and you should be able to justify it by category rather than by memory of a number.
Treats prescription monitoring program reporting as a one-time, prescribing-side obligation: forgets that the dispensing pharmacy must report each dispensing, does not know how to handle a report that must be corrected or voided, and never connects an identified error to the state's error/adverse-event reporting expectations.
Candidates associate the PMP almost entirely with the prescriber's 'must check before prescribing' duty, so the pharmacy-side submission, correction, and quality-reporting duties fall out of the answer.
What to do instead
For any scenario involving a controlled substance dispensing, add a standing checklist item: 'dispensing reported to the NJ PMP within the required timeframe, with corrections/voids submitted when data is wrong.' Separately memorize the pharmacy's internal error-review and external reporting pathway, and name which body receives what.
States that a pharmacist may immunize or manage drug therapy under a collaborative agreement without naming the prerequisites actually required in New Jersey: current licensure plus the specific certification/training, a valid protocol or agreement with the authorizing prescriber, documentation, and required reporting to the state immunization registry.
Expanded-scope topics are studied as headlines ('pharmacists can vaccinate now'), so the conditions and paperwork that make the authority lawful are lost, and candidates answer that the authority is unlimited.
What to do instead
For every scope-of-practice item, answer in a fixed order: authority (statute/regulation), credential (license plus any certification or training), authorization document (protocol or collaborative agreement, with its required content and signature), performance limits (age/vaccine/drug-class or patient-selection restrictions), and follow-up (documentation, notification to prescriber, registry reporting). If any element is missing in the facts, the correct answer is usually 'not permitted until it is in place.'
Mishandles prescription transfers and record retention: refuses all Schedule II transfers as categorically impossible, transfers without all required elements and without a documented sending/receiving record, or keeps records for a single remembered retention period without distinguishing federal and New Jersey requirements.
Candidates learn transfer rules from one practice setting or one dated summary and never update the CII/electronic-prescription nuance, so they apply an absolute rule that no longer matches practice.
What to do instead
Write out the transfer checklist as data fields (patient, drug/strength/quantity, directions, prescriber, original fill date, number of refills remaining, pharmacist identity, date of transfer) and note that a transfer must be between licensed pharmacists with a record kept by both pharmacies; verify the current status of Schedule II transfer before answering 'never.' For retention, keep a small table separating federal and New Jersey retention periods rather than guessing one number.